Tracking TBI: neuromonitoring for brain injuries
UC expert discusses advances in neurocritical care with Albany, Georgia's WALB
The University of Cincinnati's Brandon Foreman, MD, discussed advances in multimodal neuromonitoring with Albany, Georgia's WALB-TV.
Like traditional monitoring of a patient's heart rate, blood pressure and oxygen levels, multimodal neuromonitoring tracks similar brain health data points for patients with traumatic brain injuries. Measurements like blood flow, pressure, oxygen and glucose levels in the brain give actionable information over time when treating patients with severe brain trauma.
"What’s happening in the patient on day one is often very different compared to what’s happening to that patient on day three," said Foreman, associate professor of neurology and associate director of neurocritical care research in the Department of Neurology and Rehabilitation Medicine in UC’s College of Medicine and a UC Gardner Neuroscience Institute physician. "We’re learning a lot about what those patterns look like, how individual they are and how we can treat them in a more precise way tailored to that patient."
Read more about multimodal neuromonitoring work at UC.
Featured photo at top of Foreman reviewing brain data on a monitor. Photo/Andrew Higley/UC Marketing + Brand.
Related Stories
Pocket-sized population threat
June 10, 2026
The Financial Times took a deep dive into why populations around the world continue to be on the decline. The publication cited new University of Cincinnati research as part of the investigation that looks at the fall of fertility in the digital era.
Patients with developmental disabilities may benefit with an integrated care model
June 9, 2026
Researchers from the University of Cincinnati and Ohio State University have found that adults with developmental disabilities who have integrated care were less likely to go to the emergency room or be hospitalized than others who were not. Their work was published in Disability and Health Journal.
UC physician-researcher's work yields landmark five-year data for Crohn's disease drug
June 8, 2026
The University of Cincinnati College of Medicine’s Anita Afzali, MD, leads a landmark study revealing five-year efficacy and safety data for a Crohn’s disease drug called guselkumab.